Back to Market Feed

DAPTOMYCIN 500 MG VIAL

Daptomycin
$21.2443per EA

Strength

50 mg/mL

Manufacturer

NorthStar Rx LLC

NDC

16714089201

Classification

Generic

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route

INTRAVENOUS

Last Updated

4/22/2026

Active Ingredients

DAPTOMYCIN

Approval Type

Generic (ANDA)

FDA Application

ANDA208375

On Market Since

6/13/2022

Pharmacological Classes

Lipopeptide Antibacterial
Lipopeptides

Price History

1W

0.0%

1M

+2.3%

3M

+2.3%

6M

+5.7%

1Y

+5.2%

3Y

N/A

5Y

N/A

All

-14.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

DAPTOMYCIN 350 MG VIAL
Generic
00409012001•Hospira Inc.
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
70594006601•Xellia Pharmaceuticals USA LLC
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
71288001715•Meitheal Pharmaceuticals Inc.
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
71288001791•Meitheal Pharmaceuticals Inc.
$13.4180
per EA
DAPTOMYCIN 350 MG VIAL
Generic
71839010801•BE Pharmaceuticals Inc.
$13.4180
per EA
DAPTOMYCIN 500 MG VIAL
Generic
00409012201•Hospira Inc.
$20.7686
per EA
DAPTOMYCIN 500 MG VIAL
Generic
70594006001•Xellia Pharmaceuticals USA LLC
$20.7686
per EA
DAPTOMYCIN 500 MG VIAL
Generic
25021017415•Sagent Pharmaceuticals
$21.2443
per EA
DAPTOMYCIN 500 MG VIAL
Generic
25021017416•Sagent Pharmaceuticals
$21.2443
per EA
DAPTOMYCIN 500 MG VIAL
Generic
55150034401•Eugia US LLC
$21.2443
per EA